The combination of the IRAs restructured benefit with the coming wave of small-molecule specialty drug patent expirations (CDK4/6 inhibitors, oral oncology agents) will likely accelerate generic uptake rates for these drugs compared to historical patterns
has received research support for the University of Florida as principal investigator from Boehringer Ingelheim, Echosens, Inventiva, LabCorp and Perspectum and has served as a consultant for Aligos Therapeutics, Arrowhead, AstraZeneca, 89bio, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Prosciento, Sagimet Biosciences, Siemens USA and Terns Pharmaceuticals
Glucagon-receptor activation is studied for its role in supporting energy expenditure and fat-utilization pathways
The effects of mixing alcohol and Lexapro may depend on the dosage you take and how much you drink